InsidersTradesSigma
Discover the detailed record of transactions filed by Parsons James T., Director. Officer active across 1 companies, notably DiaMedica Therapeutics Inc.. Cumulatively, 2 filings have been published. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
James T. Parsons is a Director at DiaMedica Therapeutics Inc. As a board member, he participates in overseeing the company's operations and making strategic decisions. James brings significant expertise in the biopharmaceutical sector, allowing him to contribute to the growth and profitability of DiaMedica. His commitment to corporate governance ensures strong and responsible leadership.